Literature DB >> 34108617

αSMA+ fibroblasts suppress Lgr5+ cancer stem cells and restrain colorectal cancer progression.

Kathleen M McAndrews1, Karina Vázquez-Arreguín1, Changsoo Kwak1, Hikaru Sugimoto1, Xiaofeng Zheng1, Bingrui Li1, Michelle L Kirtley1, Valerie S LeBleu1,2, Raghu Kalluri3,4,5.   

Abstract

The development and progression of solid tumors is dependent on cancer cell autonomous drivers and the tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) in the TME possess both tumor-promoting and tumor-restraining functions. In the current study, we interrogated the role of αSMA+ CAFs in a genetic mouse model of metastatic colorectal cancer (CRC). Selective depletion of αSMA+ CAFs resulted in increased tumor invasiveness, lymph node metastasis, and reduced overall survival. Depletion of αSMA+ CAFs reduced BMP4 and increased TGFβ1 secretion from stromal cells, and was associated with increased Lgr5+ cancer stem-like cells (CSCs) and the generation of an immunosuppressive TME with increased frequency of Foxp3+ regulatory T cells and suppression of CD8+ T cells. This study demonstrates that αSMA+ CAFs in CRC exert tumor-restraining functions via BMP4/TGFβ1 paracrine signaling that serves to suppress Lgr5+ CSCs and promote anti-tumor immunity, ultimately limiting CRC progression.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34108617      PMCID: PMC9150816          DOI: 10.1038/s41388-021-01866-7

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   8.756


  51 in total

1.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.

Authors:  Berna C Özdemir; Tsvetelina Pentcheva-Hoang; Julienne L Carstens; Xiaofeng Zheng; Chia-Chin Wu; Tyler R Simpson; Hanane Laklai; Hikaru Sugimoto; Christoph Kahlert; Sergey V Novitskiy; Ana De Jesus-Acosta; Padmanee Sharma; Pedram Heidari; Umar Mahmood; Lynda Chin; Harold L Moses; Valerie M Weaver; Anirban Maitra; James P Allison; Valerie S LeBleu; Raghu Kalluri
Journal:  Cancer Cell       Date:  2014-05-22       Impact factor: 31.743

2.  Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications.

Authors:  Anguraj Sadanandam; Xin Wang; Felipe de Sousa E Melo; Joe W Gray; Louis Vermeulen; Douglas Hanahan; Jan Paul Medema
Journal:  Cell Cycle       Date:  2014-01-09       Impact factor: 4.534

Review 3.  Mesenchymal cells of the intestinal lamina propria.

Authors:  D W Powell; I V Pinchuk; J I Saada; Xin Chen; R C Mifflin
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

Review 4.  Origin and functional heterogeneity of fibroblasts.

Authors:  Valerie S LeBleu; Eric G Neilson
Journal:  FASEB J       Date:  2020-02-10       Impact factor: 5.191

5.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy.

Authors:  Anguraj Sadanandam; Costas A Lyssiotis; Krisztian Homicsko; Eric A Collisson; William J Gibb; Stephan Wullschleger; Liliane C Gonzalez Ostos; William A Lannon; Carsten Grotzinger; Maguy Del Rio; Benoit Lhermitte; Adam B Olshen; Bertram Wiedenmann; Lewis C Cantley; Joe W Gray; Douglas Hanahan
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

6.  Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis.

Authors:  Valerie S LeBleu; Yingqi Teng; Joyce T O'Connell; David Charytan; Gerhard A Müller; Claudia A Müller; Hikaru Sugimoto; Raghu Kalluri
Journal:  Nat Med       Date:  2013-01-27       Impact factor: 53.440

7.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

8.  Oncogenic Kras drives invasion and maintains metastases in colorectal cancer.

Authors:  Adam T Boutin; Wen-Ting Liao; Melody Wang; Soyoon Sarah Hwang; Tatiana V Karpinets; Hannah Cheung; Gerald C Chu; Shan Jiang; Jian Hu; Kyle Chang; Eduardo Vilar; Xingzhi Song; Jianhua Zhang; Scott Kopetz; Andrew Futreal; Y Alan Wang; Lawrence N Kwong; Ronald A DePinho
Journal:  Genes Dev       Date:  2017-03-13       Impact factor: 11.361

9.  COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS.

Authors:  Zheying Zhang; Cheng Fang; Yongxia Wang; Jinghang Zhang; Jian Yu; Yongxi Zhang; Xianwei Wang; Jiateng Zhong
Journal:  Int J Oncol       Date:  2018-08-22       Impact factor: 5.650

10.  Collagen production and niche engineering: A novel strategy for cancer cells to survive acidosis in DCIS and evolve.

Authors:  Mehdi Damaghi; Hidetoshi Mori; Samantha Byrne; Liping Xu; Tingan Chen; Joseph Johnson; Nathan D Gallant; Andriy Marusyk; Alexander D Borowsky; Robert J Gillies
Journal:  Evol Appl       Date:  2020-11-04       Impact factor: 5.183

View more
  4 in total

1.  Dermal αSMA+ myofibroblasts orchestrate skin wound repair via β1 integrin and independent of type I collagen production.

Authors:  Kathleen M McAndrews; Toru Miyake; Ehsan A Ehsanipour; Patience J Kelly; Lisa M Becker; Daniel J McGrail; Hikaru Sugimoto; Valerie S LeBleu; Yejing Ge; Raghu Kalluri
Journal:  EMBO J       Date:  2022-02-25       Impact factor: 11.598

Review 2.  Stemness, Inflammation and Epithelial-Mesenchymal Transition in Colorectal Carcinoma: The Intricate Network.

Authors:  Inese Briede; Dainis Balodis; Janis Gardovskis; Ilze Strumfa
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

Review 3.  Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment.

Authors:  Jeong-Yeon Mun; Sun-Hee Leem; Jun Ho Lee; Hyuk Soon Kim
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

Review 4.  Pleiotropic effects of DCLK1 in cancer and cancer stem cells.

Authors:  Dibyashree Chhetri; Srinivasan Vengadassalapathy; Santhosh Venkadassalapathy; Varadharaju Balachandran; Vidhya Rekha Umapathy; Vishnu Priya Veeraraghavan; Selvaraj Jayaraman; Shankargouda Patil; Ashok Iyaswamy; Kanagaraj Palaniyandi; Dhanavathy Gnanasampanthapandian
Journal:  Front Mol Biosci       Date:  2022-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.